Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,175.97 -23.72 -0.74%
FTSE 100 6,674.74 -7.02 -0.11%
DAX 9,544.19 -55.90 -0.58%
Ticker Volume Price Price Delta
NIKKEI 14,527.81 -18.46 -0.13%
TOPIX 1,170.98 -2.83 -0.24%
HANG SENG 22,516.65 7.01 0.03%

Kips Bay Medical Announces Operating and Financial Results and Conference Call Date for First Quarter 2013



  Kips Bay Medical Announces Operating and Financial Results and Conference
  Call Date for First Quarter 2013

Business Wire

MINNEAPOLIS -- April 26, 2013

Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS)
announced today that Kips Bay will release operating and financial results for
the first quarter ended March 30, 2013 on Thursday, May 9, 2013 prior to
market open and will hold a conference call to discuss those results at 9:00
A.M. (Eastern Time).

The call can be accessed in the following ways:

  * In the Investors section of the Kips Bay’s website: www.KipsBayMedical.com
  * By telephone: For both “listen-only” participants and those participants
    who wish to take part in the question-and-answer portion of the call, the
    telephone dial-in number in the U.S. is 888-713-4209. For participants
    outside the U.S., the dial-in number is 617-213-4863. The access code for
    all callers is 38706281.
  * Through an audio replay: A replay of the conference call will be available
    beginning at 11:00 A.M. on May 9, 2013 and ending at 11:59 P.M. on May 16,
    2103. The dial-in number for U.S. participants is 888-286-8010. For
    participants outside the U.S., the replay dial-in number is 617-801-6888.
    The replay access code for all callers is 97953617.

About Kips Bay Medical

Kips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis,
Minnesota, is a medical device company focused on manufacturing and
commercializing its external saphenous vein support technology, or eSVS MESH
for use in coronary artery bypass grafting surgery. The eSVS MESH is a nitinol
mesh sleeve that, when placed over a saphenous vein graft during CABG surgery,
is designed to improve the structural characteristics and long-term
performance of the saphenous vein graft. Additional information about Kips Bay
Medical, Inc. can be found at www.KipsBayMedical.com.

Contact:

Kips Bay Medical, Inc.
Manny Villafaña, 763-235-3540
Chairman and Chief Executive Officer
Manny.Villafana@KipsBayMedical.com
or
Scott Kellen, 763-235-3540
Chief Operating Officer and Chief Financial Officer
Scott.Kellen@KipsBayMedical.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement